Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 21.76 HKD -2.16% Market Closed
Market Cap: HK$7.3B

Zylox-Tonbridge Medical Technology Co Ltd
Investor Relations

Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

Show more
Loading
2190
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Zhong Zhao Ph.D.
Founder, Chairman & CEO
No Bio Available
Mr. Yang Xie
Senior VP of Sales & Marketing and Executive Director
No Bio Available
Dr. Zheng Li
Senior VP, GM of Neurovascular Business & Executive Director
No Bio Available
Mr. Quanwei Yuan
CFO & Joint Company Secretary
No Bio Available
Ms. Sau In Kwan
Joint Company Secretary
No Bio Available

Contacts

Address
ZHEJIANG
Hangzhou
1st & 2nd Floors, Building 1, No. 18 Keji Avenue, Yuhang District
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett